|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yeh hong zen"
Showing items 1-18 of 18 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2019-11 |
Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
|
Lee, Shou-Wu;Lee, Teng-Yu;Peng, Yen-Chun;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen |
| 亞洲大學 |
2019-02 |
Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
|
Pen, Yen-Chun;Peng, Yen-Chun;Huang, Lam-Ru;Huang, Lam-Ru;Lin, Cheng-Li;Lin, Cheng-Li;Hsu, Wan-Yun;Hsu, Wan-Yun;Chan, Chi-Sen;Chang, Chi-Sen;Yeh, Hong-Zen;Yeh, Hong-Zen;高嘉鴻;Kao, Chia-Hung |
| 亞洲大學 |
2018-11 |
The association between bowel obstruction and the management of cholelithiasis and cholecystitis in elderly patients: A population-based cohort study.
|
Pen, Yen-Chun;Peng, Yen-Chun;Lin, Cheng-Li;Lin, Cheng-Li;Yeh, Hong-Zen;Yeh, Hong-Zen;Chan, Chi-Sen;Chang, Chi-Sen;高嘉鴻;Kao, Chia-Hung |
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α
|
Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 亞洲大學 |
2018-07 |
Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
|
Pen, Yen-Chun;Peng, Yen-Chun;Lin, Cheng-Li;Lin, Cheng-Li;Hsu, Wan-Yun;Hsu, Wan-Yun;Ch, Wai-Keung;Chow, Wai-Keung;Lee, Show-Wu;Lee, Show-Wu;Yeh, Hong-Zen;Yeh, Hong-Zen;Chia-Chang, Chia-Chang C;Chen, Chia-Chang;高嘉鴻;Kao, Chia-Hung;* |
| 中山醫學大學 |
2017-12 |
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up
|
Liao, Yi-Jun;Li, Yen-Chang;Lee, Shou-Wu;Wu, Chun-Ying;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen;Lee, Teng-Yu |
| 中山醫學大學 |
2017-11-30 |
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
|
Huang, Yao-Kuang;Yen, Chieh-Ling;Shiu, Sz-Iuan;Lee, Shou-Wu;Chang, Pi-Yi;Yeh, Hong-Zen;Lee, Teng-Yu |
| 中山醫學大學 |
2017-06 |
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype
|
Lee, Shou-Wu;Yang, Sheng-Shun;Lee, Teng-Yu;Yeh, Hong-Zen;Lu, I-Ta;Chang, Chi-Sen |
| 中山醫學大學 |
2017-05-15 |
Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus
|
Lee, Shou-Wu;Lien, Han-Chung;Lee, Teng-Yu;Tung, Chun-Fang;Yeh, Hong-Zen;Chang, Chi-Sen |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2009 |
Heparanase Inhibitor Pi-88 as Adjuvant Therapy for Hepatocellular Carcinoma after Curative Resection: A Randomized Phase Ii Trial for Safety and Optimal Dosage
|
劉俊人; 李伯皇; 胡瑞恆; 吳誠中; 鄭隆賓; 林炳文; 莫景棠; 葉宏仁; 何明志; 楊勝舜; 陳培哲; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立臺灣大學 |
2009 |
Il-10 Promoter Gene Polymorphisms and Sustained Response to Combination Therapy in Taiwanese Chronic Hepatitis C Patients
|
莊淨媛; 楊勝舜; 張繼森; 葉宏仁; 高嘉宏; CHUANG, JING-YUAN; YANG, SHENG-SHUN; CHANG, CHI-SEN; YEH, HONG-ZEN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2006 |
Changes of Soluble Cd26 and Cd30 Levels Correlate with Response to Interferon Plus Ribavirin Therapy in Patients with Chronic Hepatitis C
|
楊勝舜; 傅令嫻; 張繼森; 葉宏仁; 陳儉鏗; 高嘉宏; YANG, SHENG-SHUN; FU, LIN-SHIEN; CHANG, CHI-SEN; YEH, HONG-ZEN; CHEN, GRAN-HUM; KAO, JIA-HORNG |
| 國立成功大學 |
2005-09-21 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen, Li-Tzong; Lin, Jaw-Town; Tai, John-Jen; Chen, Gran-Hum; Yeh, Hong-Zen; Yang, Sheng-Shun; Wang, Hsiu-Po; Kuo, Sung-Hsin; Sheu, Bor-Shyang; Jan, Chang-Ming; Wang, Wen-Ming; Wang, Tsang-En; Wu, Chew-Wun; Chen, Chi-Long; Su, Ih-Jen; Jacqueline Whang-Peng; Cheng, Ann-Lii |
Showing items 1-18 of 18 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
